GlassScriptPhysician profile
Monica Edith Lopez
NPI 1508081316
$2,680.29
in general payments reported to CMS, 2019-2025
33 companies · $16.78 in 2025
The $16.78 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $680 · 2020: $204 · 2021: $276 · 2022: $509 · 2023: $644 · 2024: $350 · 2025: $16.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,010.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $444.60 | 2019-2023 | |
| Pfizer INC. | $342.55 | 2019-2024 | |
| Astellas Pharma US INC | $240.21 | 2022-2024 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $193.53 | 2019-2024 | Slynd |
| Hologic Sales and Service, LLC | $146.95 | 2019-2024 | Myosure Tissue Removal Device |
| Lupin INC. | $146.53 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $127.15 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $117.26 | 2023-2024 | Myfembree |
| Organon LLC | $91.65 | 2022-2023 | Nexplanon |
| Allergan, INC. | $87.02 | 2019-2020 | |
| Intuitive Surgical, INC. | $78.65 | 2023 | Da Vinci Surgical System |
| Merck Sharp & Dohme LLC | $65.09 | 2019-2021 | |
| Shield Therapeutics INC | $63.86 | 2024 | |
| Therapeuticsmd, INC. | $57.18 | 2019-2020 | |
| Duchesnay USA Incorporated | $52.80 | 2019-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $50.83 | 2023 | Exparel |
| Coopersurgical, INC. | $36.50 | 2019-2021 | |
| Avion Pharmaceuticals | $35.89 | 2022 | |
| Innovation Technologies INC | $32.84 | 2023 | Irrisept |
| Vertex Pharmaceuticals Incorporated | $30.63 | 2019 | |
| Ethicon US, LLC | $30.50 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $26.76 | 2019-2020 | |
| Evofem Biosciences, INC. | $24.35 | 2021 | |
| Millicent US INC | $23.16 | 2024 | Intrarosa |
| Vertical Pharmaceuticals, LLC | $20.86 | 2020 | |
| Meditrina | $18.32 | 2023 | |
| Aspira Women'S Health INC | $18.31 | 2022 | |
| Minerva Surgical, INC | $16.78 | 2025 | |
| Myovant Sciences INC. | $16.64 | 2022 | |
| Agile Therapeutics, INC. | $15.23 | 2023 | Twirla |
| Exact Sciences Corporation | $14.19 | 2023 | Cologuard Collection Kit |
| Biogen, INC. | $13.47 | 2024 | Vumerity |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.